For Debate What is the Role of Autoimmunity in Aids?

References

• Staughton R. Skin manifestations in AIDS patients. Br J Clin Practice -Symposium Suppl 1990; 71: 109–113
   PubMedGoogle Scholar
• Kaye BR. Rheumatologic manifestations of infection with human immunodeficiency virus (HIV). Annals of Internal Med 1989; 111(2)158–167
   PubMed Web of Science ®Google Scholar
• Stricker RB. Hemostatic abnormalities in HIV disease. Hematol Oncol Clinics of N America 1991; 5(2)249–265
   PubMed Web of Science ®Google Scholar
• Buskila D, Gladman D. Musculoskeletal manifestations of infection with HIV. Reviews of Infectious Diseases; 1990; 12: 223–235
   PubMedGoogle Scholar
• Even P, Venet A, Iral Biet D., Tourani JM, Lorenstern W, Andrieu JM., Andrieu JM, Bach JF, Even P. Autoimmunity and immunopathy in viral diseases Autoimmune aspects of HIV infection. Roy Soc Med Services Ltd 1988; 141: 7–22
   Google Scholar
• Martinez A, Marco M, de IHera A. Immuno-logical consequences of HIV infection. Lancet 1987; ii: 454–456
   Google Scholar
• Schattner A, Rager-Zisman A. Virus induced autoimmunity. Rev Infect Dis 1990; 12: 204–222
   PubMedGoogle Scholar
• Malatzky-Goshen E, Shoenfeld Y. AIDS and autoimmunity. Autoimmunity 1989; 3(3)201–212
   Web of Science ®Google Scholar
• Morrow WJ, Isenberg DA, Sobol RE, Stricker RB, Kieber-Emmons T. AIDS virus infection and autoimmunity. Clin Immunol Immunopath 1991; 58: 163–180
   PubMedGoogle Scholar
• Habeshaw J, Dalgleish AG, Bountiff L. The HIV envelope and its interaction with cellular proteins. Immunol Today 1990; 11: 418–425
   PubMedGoogle Scholar
• Fauci AS. The pathogenesis of AIDS. Science 1989; 233: 617–622
   Google Scholar
• Dalgleish AG, Manca F, Habeshaw J. The pathogenesis of HIV induced disease. AIDS and the new viruses, AG Dalgleish, R Weiss. Academic Press, London 1990
   Google Scholar
• Via CS, Shearer GM. Autoimmunity and AIDS. Curr Opin Immunol 1989; 4: 753–756
   Google Scholar
• Dalgleish AG. The pathogenesis of AIDS. J Roy Coll Phys 1992; 26: 152–158
   PubMedGoogle Scholar
• Via CS, Morse HC, Shearer GM. Altered immunoregu-lation and autoimmune aspects of HIV infection: relevant murine models. Immunol Today 1990; 11,7: 250–254
   Google Scholar
• Sheppard H, Ascher MS, McRae B. The initial outcome to HIV and immune system activation determine the outcome of disease. J. AIDS 1991; 4: 704–712
   PubMed Web of Science ®Google Scholar
• Simmonds P, Beatson D, Cuthbert R. Determinants of HIV disease progression. Lancet 1987; 338: 1159–1163
   Google Scholar
• Kennedy PGE. Neurological aspects of lentiviral infection in animals. Neurological aspects of human retroviruses, P. Rudge. Bailliere Tindall, London 1992; 41–60
   Google Scholar
• Dalgleish AG. The immunology of retrovirus diesase. Neurological aspects of human retroviruses, P. Rudge. Bailliere Tindall, London 1992; 23–40
   Google Scholar
• Bangham CRM, Daenke S, Phillips RE. Eryth-matic amplification of exogenous and endogenous retroviral sequences from DNA of patients with TSP. EMBO Journal 1988; 7: 4179–4184
   PubMed Web of Science ®Google Scholar
• Cruickshank JK, Rudge P, Dalgleish AG. Tropical spastic paraparesis and HTLV-1 in the UK. Brain 1989; 112: 1057–1090
   PubMed Web of Science ®Google Scholar
• Dalgleish AG, Richardson J, Matutes E. HTLV-1 in TSP lymphocytes culture and serological response. AIDS Res Hum Retroviruses 1988; 4: 476–486
   Web of Science ®Google Scholar
• Richardson JH, Edwards A, Cruickshank JK, Rudge P, Dalgleish AG. In-vivo cellular tropism of HTLV-1. J Virology 1990; 64: 5682–7
   PubMed Web of Science ®Google Scholar
• Ohara Y, Iwasaki Y, Izumo S, Kobayashi I, Yoshioka A. Search for HTLV-1 by PCR in HAM. Arch Virol 1992; 124: 31–43
   PubMedGoogle Scholar
• Usuku J, Nishizawa M, Matsuki K. Association of a particular AA sequence of HLA DRBI chain with HAM. Eur J Immunol 1990; 20: 1603–1607
   PubMed Web of Science ®Google Scholar
• Dalgleish AG, Beverley PCL, Clapham PR, Crawford DH, Greaves MF, Weiss RA. The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Natures 1984; 312: 763–767
   PubMed Web of Science ®Google Scholar
• Autran B, Giorgi JV. Activated CD8 + cells in HIV related diseases in immunodeficiency in HIV infection and AIDS. Karger, Basel 1992; 171–184
   Google Scholar
• Giorgi JV. CD4 counts in relation to markers of immune activation. HIV infection and AIDS. Karger, Basel 1992; 1–17
   Google Scholar
• Pinto L, Covas MJ, Viclonnio RM. Loss of CD45RA and gain of CD45RO after in vitro activation of lymphocytes from HIV infected patients. Immunology 1991; 73: 147–150
   PubMed Web of Science ®Google Scholar
• Staal F, Roederer M, Bubp J, Mole LA, Anderson MT, Raju PA, Israelski DM, Deresinski SC, Moore WA, Herzernberg LA, Herzenberg LA. CD20 expression is increased on B lymphocytes from HIV-infected individuals. J of AIDS 1992; 5: 627–632
   PubMed Web of Science ®Google Scholar
• Spickett GP, Beattie RE, Farrant J, Bryant A, Dalgleish AG, Webster ADB. Effect on HIV on antigen presenting cells immunoglobulin production by normal B lymphocytes in vitro. AIDS. Res Hum Retro 1989; 5(3)355–358
   PubMedGoogle Scholar
• Stricker RB, McHugh TM, Moody DJ, Morrow WJW, Stiles DP, Shuman MA, Levy JA. An AIDS-related cytotoxic autoantibody reacts with a specific antigen on stimulated CD4+ T cells. Nature 1987; 327: 710–713
   PubMed Web of Science ®Google Scholar
• Daniel V, Weimer R, Schimpf K, Opelz G. Autoan-tibodies against CD4 and CD8 positive T lymphocytes in HIV infected haemophilia patients. Vox Surg 1989; 57: 172
   PubMed Web of Science ®Google Scholar
• Daniel V, Schimpf K, Opelz G. Lymphocyte autoan-tibodies and alloantibodies in HIV positive haemophilia patients. Clin Exp Immunol 1989; 75: 178
   PubMed Web of Science ®Google Scholar
• Dorsett B, Gonin W, Ioachim H. Presence and prognostic significance of antilymphocyte antibodies in symptomatic and asymptomatic patients. Ach Intern Med 1990; 15: 1025
   Google Scholar
• Chams V, Jouault T, Fenouillet E, Gluckman JC, Klatzmann D. Detection of anti-CD4 autoantibodies in the sera of HIV-infected patients using recombinant soluble CD4 molecules. AIDS 1988; 2: 353
   Google Scholar
• Kowalski M, Ardman B, Basiripour L, Lu Y, Blohm D, Haseltine W, Sodroski J. Antibodies to CD4 in individuals infected with human immunodeficiency virus type 1. Proc Nail Acad Sci USA 1989; 86: 3346
   PubMed Web of Science ®Google Scholar
• Sekigawa I, Groopman JE, Allan JD, Ikeuchi K, Biberfield G, Takatsuki K, Byrn RA. Characterization of autoantibodies to the CD4 molecule in human immunodeficiency virus infection. Clin Immunol Immunopathol 1991; 58: 145
   PubMedGoogle Scholar
• Chams V, Thierry I, Klatzmann D. Biological properties of anti-CD4 autoantibodies purified from HIV-infected patients. AIDS 1991; 5: 565
   PubMed Web of Science ®Google Scholar
• Wilks D, Walker LC, Habeshaw JA, Youle M, Gazzard B, Dalgleish AG. Antibodies to anti-CD4 monoclonal antibodies in HIV positive people. AIDS 1990; 4: 113
   PubMed Web of Science ®Google Scholar
• Callahan LN, Roderiquez G, Mallinson M, Norcross MA. Analysis of HIV-induced autoantibodies to cryptic epitopes on human CD4. J of Immunol 1992; 149: 2194–2202
   PubMed Web of Science ®Google Scholar
• Thiriart C, Goudsmit J, Schellenkens P, Barin F, Zagury D, Wilde MD, Bruck C. Antibodies to soluble CD4 in HIV-infected individuals. AIDS 1988; 2: 345
   PubMed Web of Science ®Google Scholar
• Karpatkin S, Nardi M. Autoimmune anti-HIV gpl20 antibody with antiidiotype-like activity in sera and immune complexes of HIV-1 related immunologic thrombocytopenia. J Clin Investigation 1992; 89(2)356–364
   PubMed Web of Science ®Google Scholar
• Ribera E, Ocana I, Almirante B, Gomez J, Monreal P, Martinez Vazquez JM. Autoimmun neutropenia and thrombocytopenia associated with development of antibodies to human immunodeficiency virus. J. Infection 1989; 18(2)167–170
   PubMed Web of Science ®Google Scholar
• Habeshaw J, Dalgleish AG. The relevance of HIV ENV/CD4 interactions to the pathogenesis of AIDS. J AIDS 1989; 2: 457–368
   PubMed Web of Science ®Google Scholar
• Morse HC, Chattopahyay SK, Makino M, Fredericksen TN, Hugin AW, Hartley JW. Retrovirus induced immuno-deficiency in the mouse MAIDS as a model for AIDS. AIDS 1992; 6: 607–622
   PubMed Web of Science ®Google Scholar
• Popov J, McGraw T, Hofmann B, Vowels B, Shum A, Nisha-nian P, Fahey JL. Acute lymphoid changes and ongoing immune activation in SIV infection. J of AIDS 1992; 5: 391–399
   PubMed Web of Science ®Google Scholar
• Acha-orbea H, Palmer E. M/S-a retrovirus exploits the immune system. Immunol Today 1991; 12: 356–361
   PubMedGoogle Scholar
• Hounsell E, Renouf D, Liney D, Dalgleish AG, Habeshaw JA. A proposed molecular model of gpl20 showing strucutral features of a T cell alloepitope. Mol Aspects Med 1991; 12(4)283–296
   PubMed Web of Science ®Google Scholar
• Golding H, Robey FH, Gates FT, Linder W, Beining PR, Hoffman T, Golding B. Identification of homologous regions in human immunodeficiency virus I gp41 and human MHC Class II Bl domain. J Exp Med 1988; 167: 914–923
   PubMed Web of Science ®Google Scholar
• Grassi F, Menerveri R, Gullberg M, Lopalco L, Rossi GB, Lanza P, De Santis C, Brattsand G, Butto S, Ginelli E, Beretta A, Siccardi AG. Human immunodeficiency virus type I gpl20 mimics a hidden monomorphic epitope borne by class I major histocompability complex heavy chains. J Exp Med 1991; 174: 53–62
   PubMed Web of Science ®Google Scholar
• Israel-Biet D, Venet A, Beldjord D, Andrieu JM, Even P. Autoreactive cytotoxicity in HIV-infected individuals. Clin Exp Immunol 1990; 81: 18–24
   PubMed Web of Science ®Google Scholar
• Pugliese O, Viora M, Camponeschi B, Cordiali FEI, Caprilli F, Chersi A, Evengelista M, Di Massimo AM., Collizi V. A gpl20 HIV peptide with high similarity to HLA Class II β chains enhances PPD-specific and autoreactive T cell activation. Clin Exp Immunol 1992; 90(2)170
   PubMed Web of Science ®Google Scholar
• Hoffenbach A, Langlade-Demoyen P, Dadaglio G, Vilmer E, Michel F, Mayaud C, Autran B, Plata F. Unusually high frequencies of HIV-specific cytotoxic T lymphocytes in humans. J Immunol 1989; 142: 452–462
   PubMed Web of Science ®Google Scholar
• Manca F, Habeshaw JA, Dalgleish AG. The naive repertoire of T cell responses to gpl20. J Immunol 1991; 146: 1964–1971
   PubMedGoogle Scholar
• Knulst AC, Bazuin CB, Brenner R. Prevention of lethal GVHD by a simple low dose infection of anti-T cell monoclonal antibody to allograft receptor. Eur J Immunol 1991; 21: 103–107
   PubMed Web of Science ®Google Scholar
• Pantaleo G, Graziosi C, Butini L. Lymphoid organs function as major reservoirs for HIV. Proc Natl Acad Sci USA 1991; 88: 9838–9842
   PubMed Web of Science ®Google Scholar
• Clouse RA, Cosetine L, Weih KA. The HIV envelope has intrinsic capacity to stimulate monokine secretion. J Immunol 1991; 147: 2892–2901
   PubMed Web of Science ®Google Scholar
• Rieckmann P, Poli G, Fox C, Kehrl J, Fauci AS. Recombinant gpl20 specifically enhances TNF production and Ig secretion. J Immol 1991; 147: 2922–2927
   PubMedGoogle Scholar
• Ameisen JC, Capron A. Cell dysfunction and depletion in AIDS: the programmed cell death hypothesis. Immunol Today 1991; 12: 102–105
   PubMedGoogle Scholar
• Banda NK, Bernier J, Kurhara DK, Kurrle R, Haigwood N, Sekaly R-P, Finkel TH. Crosslinking CD4 by human immunodeficiency virus gpl20 primes T cells for activation-induced apoptosis. J Exp Med 1992; 176: 1099–1106
   PubMed Web of Science ®Google Scholar
• Se-Kyung Oh, Cruikshank WW, Raina J, Blanchard GC, Adler W, Walker J, Kornfeld H. Identification of HIV-1 envelope glycoprotein in the serum of AIDS and ARC patients. J of AIDS; 1992; 53: 251–256
   Google Scholar
• Kaufmann R, Laroche D, Buchner K, Hucho F, Rudd C, Lindschau C, Ludwig P, Hoer A, Oberdisse E, Kopp J, Korner I-J, Repke H. The HIV-1 surface protein gpl20 has no effect on transmembrane signal transduction in T cells. J of AIDS 1992; 15: 760–770
   Google Scholar
• Bjork R. HIV-1: seven facets of functional molecular mimicry. Minireview. Immunology Letters 1991; 28: 91–95
   PubMed Web of Science ®Google Scholar
• Brinkworth RI. The envelope of HIV-1 may have incorporated the CD4 binding site from HLA DQ BI. Life Sciences 1989; 45: 20iii–ix
   Web of Science ®Google Scholar
• Kion T, Hoffmann G. Anti-HIV sn danti anti-MHC antibodies in alloimmune and autoimmune mice. Science 1991; 253: 1138–1141
   PubMed Web of Science ®Google Scholar
• Stott J. Anti cell antibody in macaques. Nature 1991; 353: 393
   PubMed Web of Science ®Google Scholar
• Lombardi V, Rossi P, Romil L, Matter M, Mariani F, Poccia F, Collizi V. Letter to the Editor: HIV gpl20 epitope immunodominance in MRL/Ipr Mice. ARHR 1992; 8(6)1081
   Google Scholar
• Chan WL, Rodgers A, Hancock RD, Taffs F, Kitchin P., Far-rar G, Liew FY. Brief definitive report on 'Protection in Simian Immunodeficiency Virus-vaccinated Monkeys correlates with Anti-HLA Class I Antibody Response'. J Exp Med 1992; 176: 1203–1207
   PubMed Web of Science ®Google Scholar
• Baranski BG, Young NS. Autoimmune aspects of aplastic anemia. In Vivo 1988; 2(1)91–94
   PubMedGoogle Scholar
• Kinloch-de Loes S., Didierjean L, Rickhoff-Cantoni L, Imhof K, Perrin L., Saurat JH. Bullous pemphigoid autoan-tibodies, HIV-1 infection and puritici papular eruption. AIDS 1991; 5(4)451–454
   PubMed Web of Science ®Google Scholar
• Mayer-Siuta R, Keil LB, DeBari VA. Autoantibodies and circulating immune complexes in subjects infected with human imrnuno-deficiency virus. Med Microbiol Immunol 1988; 177(4)189–194
   PubMed Web of Science ®Google Scholar
• Krapf FE, Herrmann M, Leitmann W, Schwartlander B, Kalden JR. Circulating immune complexes in HIV-infecred persons. Klinische Wochenschrift 1990; 68(6)299–305
   PubMedGoogle Scholar
• Michaels J, Sharer LR, Epstein LG. Human immunodeficiency virus type 1 (HIV-1) infection of the nervous system: a review. Immunodef Reviews 1988; 1(1)71–104
   PubMedGoogle Scholar
• Fabricius EM, Hoegl I, Pfaeffl W. Ocular myositis as first presenting symptom of human immunodeficiency virus (HIV-1) infection and its response to high-dose cortisone treatment. Br. J. Ophthalmology 1991; 75(11)696–697
   PubMed Web of Science ®Google Scholar
• Cabello A. Myopathy associated to human immunodeficiency virus (HIV) infection. Archivos De Neurobiologia 1989; 52: 104–107
   PubMedGoogle Scholar
• Parry GJ. Peripheral neuropathies associated with human immunodeficiency virus. Ann. of Neurol 1988; 23: S49–53
   PubMed Web of Science ®Google Scholar
• Buskila D, Gladman D. Musculoskeletal manifesia-tions of infection with human immunodeficiency virus. Rev Infec Diseases 1990; 12(2)223–235
   PubMedGoogle Scholar
• Elder GA, Sever JL. Neurologic disorders associated with AIDS retroviral infection. Rev Infec Diseases 1988; 10(2)286–302
   PubMedGoogle Scholar
• Berk L, Schalm SW, Heijtink RA. Severe chronic active hepatitis (autoimmune type) mimicked by coinfetion of hepatitis C and human immunodefiency viruses. Gut 1991; 32(10)1198–1200
   PubMedGoogle Scholar
• Imberti L, Sottini A., Bettinardi A, Puoti M, Primi D. Selective deletion in HIV infection of T cells that bear specific T cell receptor Vβ sequences. Science 1991; 254: 860–864
   PubMed Web of Science ®Google Scholar
• Dalgleish AG, Wilson S, Ludlum C, Gompels M, Gazzard B, Coates ARM, Habeshaw J. T cell receptor variable gene products and early HIV-1 infection. Lancet 1992; 339: 824–28
   PubMedGoogle Scholar